Carbohydrates and cancer

Carbohydrate intake influences cancer risk primarily through its effects on blood glucose, circulating insulin, and the gut microbiome. High-glycemic diets, those heavy in refined sugars and processed grains, drive repeated insulin spikes and promote a metabolic environment that supports tumor cell growth. Colorectal cancer has the strongest and most consistent epidemiological link to carbohydrate quality, but associations also exist with bladder cancer, breast cancer, endometrial cancer, and ovarian cancer.

Refined carbohydrates cause rapid rises in blood glucose, prompting the pancreas to secrete insulin. Chronically elevated insulin activates the phosphoinositide 3-kinase (PI3K)/AKT/mTOR signaling pathway, which drives cancer cell proliferation and suppresses apoptosis (programmed cell death). High sugar intake also fuels chronic low-grade inflammation through the activation of nuclear factor kappa B (NF-kB), a transcription factor that promotes the release of pro-inflammatory cytokines and creates a microenvironment hospitable to tumor growth. On the protective side, dietary fiber is fermented by gut bacteria into short-chain fatty acids (SCFAs), particularly butyrate, which inhibit colon cancer cell proliferation, strengthen gut barrier integrity, and reduce concentrations of secondary bile acids that can act as carcinogens in the colon. Cruciferous vegetables such as broccoli and cabbage contain glucosinolates, which are hydrolyzed by the enzyme myrosinase into bioactive compounds including isothiocyanates such as sulforaphane (SFN) and indole-3-carbinol (I3C). These metabolites activate phase II detoxification enzymes, reduce oxidative DNA damage, and induce apoptosis in cancer cells. Anthocyanins, the pigments in berries and purple vegetables, exert anti-inflammatory and antioxidant effects that counteract some of the pro-carcinogenic influences of Western dietary patterns.

A systematic analysis of Global Burden of Disease (GBD) data from 1990 to 2021 found that low-fiber dietary patterns are significantly associated with colorectal cancer (CRC) burden worldwide, with mortality and disability-adjusted life years (DALYs) attributable to inadequate fiber rising over the three-decade period and showing substantial variation across regions and age groups. A separate systematic review found that high-anthocyanin diets were associated with reduced CRC risk compared to Westernized diets high in refined grains, added sugars, processed meats, and saturated fats. Research into the mechanisms linking dietary sugar to bladder cancer found that elevated glucose promotes proliferation, epithelial-mesenchymal transition, and reduced autophagy in bladder cancer cells, with epidemiological data pointing to associations between high sugar consumption and bladder cancer incidence. A prospective cohort study of 34,028 women in Singapore found no clear association between low-carbohydrate diet (LCD) scores and breast cancer risk, suggesting that carbohydrate reduction alone does not uniformly affect all cancer types. A multi-center case-control study of 163 colorectal cancer patients found that specific dietary components promote colorectal carcinogenesis partly through myosteatosis (the accumulation of fat within muscle tissue), identifying ectopic fat deposition as a mediating pathway between diet and CRC. A case-control study using data from over 3,400 Italian participants found that adherence to a healthy plant-based diet index (hPDI) was associated with reduced ovarian cancer risk.

The fiber-colorectal cancer protective relationship appears most consistent and strong across diverse populations and dietary contexts. People with insulin resistance, type 2 diabetes, or obesity face elevated cancer risk partly through carbohydrate-driven metabolic pathways: a Korean population study of nearly two million adults found that combined diabetes and excess weight significantly increased risk for cancers of the kidney, liver, and colorectum. There may be sex-specific dynamics: postmenopausal women, for whom adipose-derived estrogen is the dominant hormonal source, may be more sensitive to the insulin-signaling effects of high-glycemic diets in the context of estrogen-receptor-positive breast and endometrial cancers. The quality of carbohydrates appears to matter more than quantity: fiber-rich whole foods are consistently associated with protection, while refined sugars and ultra-processed foods are linked to harm through metabolic and inflammatory pathways.

The protective association between dietary fiber and colorectal cancer is one of the most robustly supported relationships in nutritional oncology, backed by mechanistic studies, large prospective cohort data, and burden-of-disease analyses. Evidence for refined sugar as a direct cancer risk factor is largely mechanistic and epidemiological, with fewer large trials designed around carbohydrate quality as the primary exposure. Confounders including total caloric intake, body weight, physical activity level, and overall dietary pattern make isolating the effect of carbohydrates specifically a methodological challenge. The role of the glycemic index as a standalone cancer risk predictor remains debated, and findings for specific cancer types beyond colorectal cancer are less consistent. Overall, the evidence is moderate: strong for colorectal cancer and dietary fiber, weaker and more mixed for other cancer types.

Research suggests that the quality of carbohydrate consumption matters more than quantity for cancer risk. Diets high in fiber from whole grains, vegetables, and legumes are associated with lower colorectal cancer risk, and a range of plant-derived carbohydrate components, including anthocyanins, glucosinolates, and SCFAs, may contribute additional protective effects. The evidence points toward the importance of dietary patterns rather than targeting a single nutrient.